TickerFactsScreenerDevelopers

BioNexus Gene Lab Corp (BGLC) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2018: 74.63M2019: 102.73M2020: 171.22M2021: 171.22M2022: 14.48M2023: 17.67M2024: 1.80M2025: 2.42M2.42M
2018Shares Outstanding (shares)2025
Fiscal YearShares OutstandingChange YoY
20252.42M+34.5%
20241.80M-89.8%
202317.67M+22.0%
202214.48M-91.5%
2021171.22M+0.0%
2020171.22M+66.7%
2019102.73M+37.7%
201874.63M—